Skip to content

Internet Explorer is no longer supported by this website.

For optimal browsing we recommend using Chrome, Firefox or Safari.
Heart icon (animated) heart icon (static)
Our Businesses
Explore more Johnson & Johnson sites:
Latest News

Statement on the Release of the Janssen U.S. Transparency Report

Today's Top Reads Close

Below, please find a statement on the Janssen U.S. Transparency Report from Joaquin Duato, Johnson & Johnson Executive Vice President and Worldwide Chairman, Pharmaceuticals. You can view the full report on

"We are pleased to release the inaugural Janssen U.S. Transparency Report, in which we are disclosing more information about our business practices, including those related to pricing. This report builds on our history of responsible pricing practices and our ongoing efforts to provide more transparency into how we operate. These disclosures are steps that we can take as one company as we continue to work with others in the health care system to address stakeholder concerns about U.S. health care costs." - Joaquin Duato, Executive Vice President and Worldwide Chairman, Pharmaceuticals

More from Johnson & Johnson

Back to top
You are now leaving The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.